Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details
Completed

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

NCT00053196

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +52 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • St. Francis Hospital Wilmington, Delaware, United States
View Trial Details
Completed

Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies

NCT01056614

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +41 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients

NCT02523638

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations
  • LKH Graz Graz, Austria
  • University Hospital Innsbruck Innsbruck, Austria
  • Elisabethinen Hospital Linz Linz, Austria
  • Salzburg Regional Hospital Salzburg, Austria
View all 35 locations
View Trial Details
Completed

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

NCT00588666

Conditions
Bone Marrow Diseases, Cancer, Carcinoma, +9 more
Locations
  • Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions